Noveris Health Sciences Inc. Unaware of Any Material Change

Rhea-AI Summary

Noveris Health Sciences (OTC Pink: MYCOF) reported that, at the request of CIRO, its management is unaware of any material change in the company’s operations that would explain recent increases in market activity. Noveris is a Canadian life sciences company focused on mental health and therapeutic innovation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Vancouver, British Columbia--(Newsfile Corp. - August 6, 2026) - At the request of CIRO, Noveris Health Sciences Inc. (CSE: NVRS) (FSE: 0NF1) (OTC Pink: MYCOF) (the "Company" or "Noveris") wishes to confirm that the Company's management is unaware of any material change in the Company's operations that would account for the recent increase in market activity.

Noveris is a Canadian life sciences company focused on opportunities in mental health and therapeutic innovation. Additional information concerning the Company is available under its profile on SEDAR+ at www.sedarplus.ca and at www.noveris.health.

This news release may contain assumptions, estimates, and other forward-looking statements regarding future events. Such forward-looking statements involve inherent risks and uncertainties and are subject to factors, many of which are beyond the Company's control that may cause actual results or performance to differ materially from those currently anticipated in such statements.

FOR FURTHER INFORMATION PLEASE CONTACT:

Jason Birmingham, Chief Executive Officer

Tel: +1 778-900-NVRS (6877)
Email: jb@noveris.health

Neither the Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/308445

FAQ

Why did Noveris Health Sciences (OTC Pink: MYCOF) issue a statement on material change on August 6, 2026?

Noveris Health Sciences issued the August 6, 2026 statement in response to a CIRO request. According to Noveris Health Sciences, management is unaware of any material change in operations that would account for the recent increase in market activity in its shares.

What does it mean that Noveris Health Sciences is unaware of any material change in operations?

Being unaware of any material change means Noveris Health Sciences has not identified significant operational developments explaining recent trading activity. According to Noveris Health Sciences, management knows of no undisclosed changes in the business that would reasonably account for the notable increase in market activity.

What is the business focus of Noveris Health Sciences (CSE: NVRS, OTC Pink: MYCOF)?

Noveris Health Sciences describes itself as a Canadian life sciences company focused on mental health and therapeutic innovation. According to Noveris Health Sciences, its activities center on opportunities in mental health treatment and the development of new therapeutic approaches within the broader life sciences sector.

Where can investors find official information on Noveris Health Sciences (symbol MYCOF)?

Investors can find official information under Noveris Health Sciences’ profile on SEDAR+ and on its website. According to Noveris Health Sciences, key corporate and disclosure documents are available at www.sedarplus.ca and additional company information is accessible at www.noveris.health.

How can shareholders contact Noveris Health Sciences CEO Jason Birmingham?

Shareholders can contact CEO Jason Birmingham by phone at +1 778-900-NVRS (6877) or by email at jb@noveris.health. According to Noveris Health Sciences, these contact details are provided for further information about the company and its operations.